DAYTON, Ohio–(BUSINESS WIRE)–Riverain Technologies is committed to providing cutting edge software to aid the clinician in the efficient, effective early detection of lung disease. Today, Riverain Technologies announces ClearRead CT, a breakthrough nodule detection application, has received clearance from the Food and Drug Administration (FDA). ClearRead CT is the only FDA cleared device to support concurrent reading, allowing for faster reading with proven superior automatic nodule detection